Codes / ICD10CM / T40.412

T40.412 Poisoning by fentanyl or fentanyl analogs, intentional self-harm

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by fentanyl or fentanyl analogs, intentional self-harm

Summary

This ICD code describes intentional self-harm resulting from exposure to fentanyl or its analogs. Fentanyl is a potent synthetic opioid, and its analogs share similar pharmacological effects. Intentional self-harm may involve deliberate overdose or misuse, leading to acute toxicity. The condition requires immediate medical intervention to address life-threatening effects and underlying mental health concerns.

Causes

Intentional self-harm typically results from deliberate ingestion, inhalation, or administration of fentanyl or its analogs with the intent to cause harm. This may include misuse of prescribed medications or exposure to illicit substances. The act is often associated with acute psychological distress or suicidal ideation.

Risk Factors

  • History of mental health disorders (e.g., depression, anxiety).
  • Prior suicide attempts or self-harm behaviors.
  • Access to fentanyl or its analogs (e.g., prescribed or illicit).
  • Substance use disorders involving opioids or other drugs.
  • Social isolation or lack of support systems.

Symptoms

  • Respiratory depression (slow, shallow, or absent breathing).
  • Severe drowsiness, unresponsiveness, or coma.
  • Miosis (constricted pupils).
  • Hypotension or bradycardia.
  • Muscle rigidity or hypotonia.
  • Nausea, vomiting, or gastrointestinal distress.

Diagnosis

Diagnosis involves clinical evaluation, patient history, and toxicology screening. Healthcare providers assess for signs of opioid toxicity, including respiratory depression and altered mental status. Urine or blood tests may confirm fentanyl or analog exposure. Psychiatric evaluation is critical to address intent and underlying mental health needs.

Treatment Options

Treatment focuses on stabilizing the patient and reversing toxicity. Naloxone is administered to counteract opioid effects. Supportive care, such as respiratory support or intravenous fluids, may be necessary. Long-term management includes psychiatric care, substance use treatment, and safety planning to prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timeliness of treatment. Early intervention improves outcomes, but severe cases may result in permanent harm or death. Follow-up involves ongoing mental health support, medication management, and monitoring for relapse or recurrence of self-harm behaviors.

Complications

  • Respiratory failure or arrest.
  • Hypoxic brain injury.
  • Cardiac arrhythmias or arrest.
  • Aspiration pneumonia.
  • Long-term psychological or cognitive impairment.

Lifestyle & Prevention

  • Secure storage of medications to limit access.
  • Education on safe medication use and disposal.
  • Mental health support and crisis intervention resources.
  • Avoidance of illicit drug use or mixing substances.
  • Regular follow-up with healthcare providers for at-risk individuals.

When to Seek Professional Help

Seek immediate medical attention if signs of overdose (e.g., unresponsiveness, slow breathing) or self-harm are suspected. Contact emergency services or a mental health professional for suicidal thoughts or behaviors. Prompt care is critical to prevent fatal outcomes.

Tips for Medical Coders

Document the intent (intentional self-harm) and clinical details supporting the diagnosis. Include information on exposure route, substance confirmation, and any associated mental health assessments. Ensure coding aligns with the specific ICD-10-CM guidelines for poisoning and self-harm.

Book a walkthrough

T40.412 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.